Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Complete vascular healing and sustained suppression of neointimal thickening after local delivery of advanced c-myc antisense at six months follow-up in a rabbit balloon injury model.
Kipshidze N, Iversen P, Keane E, Stein D, Chawla P, Skrinska V, Shankar LR, Mehran R, Chekanov V, Dangas G, Komorowski R, Haudenschild C, Khanna A, Leon M, Keelan MH, Moses J. Kipshidze N, et al. Cardiovasc Radiat Med. 2002 Jan-Mar;3(1):26-30. doi: 10.1016/s1522-1865(02)00149-x. Cardiovasc Radiat Med. 2002. PMID: 12479913
Update on sirolimus drug-eluting stents.
Kipshidze N, Leon MB, Tsapenko M, Falotico R, Kopia GA, Moses J. Kipshidze N, et al. Curr Pharm Des. 2004;10(4):337-48. doi: 10.2174/1381612043453315. Curr Pharm Des. 2004. PMID: 14965195 Review.
First human experience with local delivery of novel antisense AVI-4126 with Infiltrator catheter in de novo native and restenotic coronary arteries: 6-month clinical and angiographic follow-up from AVAIL study.
Kipshidze N, Iversen P, Overlie P, Dunlap T, Titus B, Lee D, Moses J, O'Hanley P, Lauer M, Leon MB. Kipshidze N, et al. Cardiovasc Revasc Med. 2007 Oct-Dec;8(4):230-5. doi: 10.1016/j.carrev.2007.04.002. Cardiovasc Revasc Med. 2007. PMID: 18053943 Clinical Trial.
Advanced c-myc antisense (AVI-4126)-eluting phosphorylcholine-coated stent implantation is associated with complete vascular healing and reduced neointimal formation in the porcine coronary restenosis model.
Kipshidze NN, Iversen P, Kim HS, Yiazdi H, Dangas G, Seaborn R, New G, Tio F, Waksman R, Mehran R, Tsapenko M, Stone GW, Roubin GS, Iyer S, Leon MB, Moses JW. Kipshidze NN, et al. Catheter Cardiovasc Interv. 2004 Apr;61(4):518-27. doi: 10.1002/ccd.20007. Catheter Cardiovasc Interv. 2004. PMID: 15065150
Update on drug-eluting coronary stents.
Kipshidze NN, Tsapenko MV, Leon MB, Stone GW, Moses JW. Kipshidze NN, et al. Expert Rev Cardiovasc Ther. 2005 Sep;3(5):953-68. doi: 10.1586/14779072.3.5.953. Expert Rev Cardiovasc Ther. 2005. PMID: 16181039 Review.
120 results